Molecular Diagnostics News and Research

RSS

BGRF scientists propose Oncofinder method for accurate analysis of gene expression data

Scientists from the Biogerontology Research Foundation (BGRF), a UK-based charity founded to support ageing research and address the challenges of a rapidly ageing population, propose a new concept for signalome-wide analysis of changes in intracellular pathways, called OncoFinder, which allows for accurate and robust cross-platform analysis of gene expression data.

19 Aug 2014

Combination of NASBA and real-time qPCR detects aspergillosis with 100% accuracy

The fungal infection invasive aspergillosis (IA) can be life threatening, especially in patients whose immune systems are weakened by chemotherapy or immunosuppressive drugs. Despite the critical need for early detection, IA remains difficult to diagnose.

14 Aug 2014

Roka Bioscience reports increased revenue of $1.4M with 107% year-over-year growth

Roka Bioscience, Inc., a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today reported its financial results for the three and six months ended June 30, 2014.

11 Aug 2014

AMP publishes updated position statement on the regulation of LDPs

The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, today reaffirmed its position that the vast majority of laboratory developed tests (LDTs), or laboratory developed procedures (LDPs)—a term coined by AMP to more appropriately capture the nature of these processes as medical services—should continue operating under the regulation of the Clinical Laboratory Improvement Amendments program at the Centers for Medicare & Medicaid Services, and not be subject to pre-market review by the U.S. Food and Drug Administration, as suggested in the draft guidance notification issued to Congress on July 31, 2014.

4 Aug 2014

New molecular test kit predicts survival outcomes in kidney cancer patients

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test kit that can predict treatment and survival outcomes in kidney cancer patients. This breakthrough was recently reported in European Urology, the world's top urology journal.

4 Aug 2014

ZeptoMetrix releases NATtrol RP Multimarker Controls - MDZ001

ZeptoMetrix Corporation, an industry leader and innovator of quality, reliable and trusted products and services for infectious disease diagnostic development, is pleased to announce the release of NATtrol RP Multimarker Controls - MDZ001.

26 Jul 2014

Molecular testing panel increases likelihood of performing correct surgery for thyroid cancer patients

The routine use of a molecular testing panel developed at UPMC greatly increases the likelihood of performing the correct initial surgery for patients with thyroid nodules and cancer, report researchers from the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter.

26 Jul 2014

AutoGenomics, Genomas sign agreement to develop DNA-guided diagnostic systems

AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity and diabetes.

7 Jul 2014

Highmark, Horizon issued positive coverage policies for Afirma Gene Expression Classifier

Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, today announced that two Blue Cross Blue Shield–affiliated organizations, Highmark Inc. and Horizon Blue Cross Blue Shield of New Jersey, have issued positive coverage policies for the company's Afirma Gene Expression Classifier (GEC).

3 Jul 2014

Biomarkers help resolve differential diagnosis between MPM and non-cancerous pleural tissue

Scientists have identified four biomarkers that may help resolve the difficult differential diagnosis between malignant pleural mesothelioma (MPM) and non-cancerous pleural tissue with reactive mesothelial proliferations (RMPs).

6 Jun 2014

NantHealth to unveil open Clinical Operating System at NHS Confederation Annual Conference and Exhibition

NantHealth, a transformational healthcare company converging science and technology through a single integrated clinical platform, will unveil the industry's first, open Clinical Operating System (cOS) for value-based, coordinated care at this year's NHS Confederation Annual Conference and Exhibition.

4 Jun 2014

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics, the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors.

From Quest Diagnostics 2 Jun 2014

Agena Bioscience acquires Sequenom’s Bioscience business

Agena Bioscience, Inc., a portfolio company of Telegraph Hill Partners (THP), today acquired the Bioscience business of Sequenom, Inc., which sells the MassARRAY® System for mass spectrometry-based detection of nucleic acids in research and clinical laboratories.

31 May 2014

Molecular Diagnostics News and Research

BGRF scientists propose Oncofinder method for accurate analysis of gene expression data

Combination of NASBA and real-time qPCR detects aspergillosis with 100% accuracy

Roka Bioscience reports increased revenue of $1.4M with 107% year-over-year growth

AMP publishes updated position statement on the regulation of LDPs

New molecular test kit predicts survival outcomes in kidney cancer patients

ZeptoMetrix releases NATtrol RP Multimarker Controls - MDZ001

Molecular testing panel increases likelihood of performing correct surgery for thyroid cancer patients

AutoGenomics, Genomas sign agreement to develop DNA-guided diagnostic systems

Highmark, Horizon issued positive coverage policies for Afirma Gene Expression Classifier

Biomarkers help resolve differential diagnosis between MPM and non-cancerous pleural tissue

NantHealth to unveil open Clinical Operating System at NHS Confederation Annual Conference and Exhibition

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

Agena Bioscience acquires Sequenom’s Bioscience business

EKF, GILUPI report data on circulating tumour cell DNA enrichment, mutation detection

Immucor's PreciseType HEA test receives FDA approval to predict blood compatibility

Foundation Medicine obtains CE mark for FoundationOne

Luminex announces group B strep as fifth assay planned for launch menu of ARIES

FDA-cleared BD MAX Enteric Bacterial Panel now available to detect bacterial pathogens

New molecular "clamps" offer powerful new tool for identifying individuals with increased risk of cancer

AMP releases report on recommendations for molecular diagnostics curriculum

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News